Skip to content

RGEN

Repligen Corporation

Stock

$181.70+4.47 (+2.52%)Close Oct 2, 2026

Operating cash flow, 2025
$117M
YoY, 2025
−33.1%
5-year CAGR
+13.4%
10-year CAGR
+22.8%

Operating cash flow

Operating cash flow by fiscal year

PeriodOperating cash flowYoY
2025$117M−33.1%
2024$175M+54.0%
2023$114M−33.8%
2022$172M+44.6%
2021$119M+90.0%
2020$63M−6.8%
2019$67M+105.1%
2018$33M+87.8%
2017$17M+132.0%
2016$7.5M−50.0%
2015$15M−18.2%
2014$18M−29.0%
2013$26M+92.9%
2012$13M—
2011$3.2M—
2010−$2.4M—